Milestone Pharmaceuticals Inc. Operating Lease Liability
Milestone Pharmaceuticals Inc. (MIST) had Operating Lease Liability of $1.19 million as of 2025-12-31, per its 10-K filed 2026-03-20.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-03-20
- 2025-12-31: Operating Lease, Liability $1.19M.
- 2024-12-31: Operating Lease, Liability $1.45M.
- 2023-12-31: Operating Lease, Liability $2.00M.
- 2022-12-31: Operating Lease, Liability $2.49M.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-12-31 | $1.19M 10-K · filed 2026-03-20 |
| 2024-12-31 | $1.45M 10-K · filed 2025-03-13 |
| 2023-12-31 | $2.00M 10-K · filed 2024-03-21 |
| 2022-12-31 | $2.49M 10-K · filed 2023-03-29 |
| 2021-12-31 | $687.00K 10-K · filed 2022-03-24 |
| 2020-12-31 | $942.00K 10-K · filed 2021-03-29 |
| 2020-09-30 | $952.00K 10-Q · filed 2020-11-13 |
| 2019-12-31 | $514.00K 10-K/A · filed 2020-10-23 |
| 2019-09-30 | $582.00K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $236.00K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $272.00K 10-Q · filed 2019-06-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B |